Eli Lilly (NYSE:LLY) Faces $7 Billion Lawsuit While Partnering With Innovative Biotech
Eli Lilly (NYSE:LLY) Lawsuit News and Biotech Expansion Update S&P 500
Eli Lilly says India response to obesity drug Mounjaro is 'positive', will focus on meeting demand